)
Tate & Lyle Expands Collaboration with BioHarvest to Accelerate Next-Generation Sweetener Innovation
Expanded sweetener molecule development programme aims to broaden access to plant‑based sweetening solutions tailored to diverse customer food and beverage categories.
London, UK – Monday May 18th, 2026 - Tate & Lyle PLC (Tate & Lyle), a global leader in ingredient solutions for healthier food and beverages, today announced the expansion of its collaboration with BioHarvest Sciences Inc. (BioHarvest), broadening the scope of their joint sweetener development programme to include multiple plant‑based sweetener molecules.
The expanded collaboration builds on the initial agreement signed in 2024 and reflects strong technical progress to date, as well as Tate & Lyle’s ambition to equip food and beverage manufacturers with a flexible toolkit of sweetening solutions that can be tailored to different formulation needs.
As customer requirements around taste, cost and labelling continue to evolve, no single sweetener can address all food and beverage category needs. Tate & Lyle’s approach focuses on developing complementary sweetening options that can be used independently or together – enabling product‑specific optimisation while supporting sugar and calorie reduction goals.
The collaboration draws on BioHarvest’s Botanical Synthesis™ platform, which supports the development of plant‑based, non‑GMO ingredients, reducing the industry’s reliance on traditional agricultural extraction for rare or hard‑to‑source botanicals. This approach aligns with Tate & Lyle’s focus on delivering ingredient innovation that balances performance, scalability and responsible sourcing considerations.
The partnership builds on Tate & Lyle’s long‑standing commitment to sugar and calorie reduction and its track record in sweetener innovation. The company’s heritage includes major industry milestones, from the discovery of sucralose in 1976, to the commercialisation at scale of allulose in 2015 and high‑purity bioconverted stevia Reb M in 2018.
Today, Tate & Lyle’s development pipeline is focused on advancing sweetening solutions that deliver great taste while supporting sugar and calorie reduction, helping customers meet evolving consumer expectations around health and wellbeing. This includes sweet ingredients that reduce sugar and calories and have the potential to support broader health and wellbeing needs.
A 2025 proprietary Tate & Lyle survey across seven global markets found that over half of respondents planned to... Read the full article here
)
)
)
)
){kind=logo}
)
)
)
)
)